460. Deputy Robert O'Donoghue asked the Minister for Health the steps that are being taken to ensure urgent access to the medication welireg (belzutifan) (details supplied); whether compassionate or exceptional access mechanisms are available while national reimbursement processes are ongoing; the safeguards currently in place to protect such patients from avoidable permanent harm during administrative delays; and if…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Medicinal Products.
1,228 questions match, newest first.
461. Deputy Martin Daly asked the Minister for Health the action her Department and the HSE have taken on the proposed introduction of a national programme for the safe disposal of unused medications in the community in line with EU Directive 2001/83/EC; if she will commit to pursuing this matter further with a view to establishing a safe, consistent and accessible return system through community pharmacies nationwid…
184. Deputy Ryan O'Meara asked the Minister for Health for an update on the new framework agreements on the pricing and supply of medicines; and if she will make a statement on the matter. [6669/26]
188. Deputy David Cullinane asked the Minister for Health the contingency plan and guidance in place and issued by the HSE in response to the shortages of certain salbutamol products; the list of salbutamol products which are approved for reimbursement; whether each of these is in stock; the availability of substitute products for which a reimbursement price has not been agreed but which have been identified as an ap…
200. Deputy Marie Sherlock asked the Minister for Health the expenditure cost under the community drug scheme for continuous glucose monitoring (CGM) sensors with associated systems for each of the years 2023, 2024 and 2025; the number of patients availing of CGM sensors under the scheme for each year; the number of those patients with type 1 and type 2 diabetes; and if she will make a statement on the matter. [6792/…
217. Deputy Pádraig Rice asked the Minister for Health if a new agreement with respect to the pricing and supply of medicines contains any provisions which would see the procurement and use of pharmaceuticals manufactured by a company (details supplied) discontinued where alternatives exist; if not, to state whether this agreement will lead to an increase in the procurement of pharmaceuticals manufactured by this com…
948. Deputy Louis O'Hara asked the Minister for Health if a person (details supplied) qualifies for reimbursement of expenses on saxenda injections; and if she will make a statement on the matter. [5637/26]
60. Deputy Ruairí Ó Murchú asked the Minister for Health the reason ostomy products are not included on the long-term illness scheme; if ostomy products were ever considered for the long term illness scheme; if so, when; and if she will make a statement on the matter. [3641/26]
116. Deputy John Lahart asked the Minister for Health for an update on the accessibility of the drug givinostat for patients with Duchenne muscular dystrophy. [5070/26]
510. Deputy Ciarán Ahern asked the Minister for Health to intervene in the case of a person (details supplied) to ensure that they can access vital medicines; and if she will make a statement on the matter. [5112/26]
272. Deputy William Aird asked the Minister for Health the steps being taken to introduce a formal compassionate use programme in Ireland for orphan drugs, in light of the fact that several EU member states already have such programmes allowing patients early access to potentially life-saving treatments prior to full market authorisation; when such a programme will be established to ensure patients in Ireland are not…
281. Deputy William Aird asked the Minister for Health if she will outline the Government’s position on ensuring equitable access to orphan medicines given the current restrictions and the consequences for those affected; if she will provide timelines for the publication and funding of the new national rare disease plan; and if she will make a statement on the matter. [4531/26]
1047. Deputy Darren O'Rourke asked the Minister for Health an update on the approval status of the drug givinostat; if officials from her Department have been in contact with their counterparts in the North to examine the possibility of children with Duchenne muscular dystrophy accessing treatment in the North as an interim measure; and if she will make a statement on the matter. [4348/26]
1057. Deputy Brian Brennan asked the Minister for Health whether she is considering making Ryeqo available in Ireland for women suffering with endometriosis; and if she will make a statement on the matter. [4403/26]
2205. Deputy Pearse Doherty asked the Minister for Health if she will ensure that adults have access through the health service to burosumab for treatment for hypophosphataemia; and if she will make a statement on the matter. [74617/25]
2220. Deputy Pádraig Rice asked the Minister for Health if her attention has been drawn to an equivalent hormone replacement therapy scheme in another jurisdiction (details supplied); if she will conduct an equality impact assessment; and if she will make a statement on the matter. [74723/25]
2303. Deputy Liam Quaide asked the Minister for Health the current status of supply of estradot (estradiol transdermal) patches in the State; the duration and cause of any supply disruptions affecting this product in 2024 and 2025; the steps taken by her Department and the HSE to mitigate these shortages; and whether she will provide a timeline for full restoration of supply; and if she will make a statement on the m…
2304. Deputy Liam Quaide asked the Minister for Health if she will review the current dispensing arrangements under the free HRT scheme which limit hormone replacement therapy to one month’s supply at a time; the rationale for this restriction; the impact it has had on continuity of care during ongoing supply disruptions, including for estradot patches; if consideration has been given to allowing multi-month dispensi…
431. Deputy Pádraig Rice asked the Minister for Health to address the issue of access to oral immunotherapy for children with nut allergies; for an update in respect of the HSE senior leadership team’s decision on the medicine in question; and if she will make a statement on the matter. [73118/25]
316. Deputy Niamh Smyth asked the Minister for Health to review the case of a person (details supplied); the reasons this person was refused the treatment referenced in the correspondence; the options available to them; and if she will make a statement on the matter. [70569/25]
323. Deputy Ruairí Ó Murchú asked the Minister for Health if consideration will be given to the inclusion of all ostomy products on the long term illness scheme; if she will remove the need for a prescription for these products; and if she will make a statement on the matter. [70636/25]
364. Deputy Réada Cronin asked the Minister for Health the position regarding the addition of the drug veozah to the free HRT scheme; and if she will make a statement on the matter. [70837/25]
847. Deputy Mairéad Farrell asked the Minister for Health the work her Department is doing to progress the approval from HSE Medicines Management Programme for dupilumab for the treatment of paediatric eosinophilic oesophagitis; and if she will make a statement on the matter. [69050/25]
998. Deputy Albert Dolan asked the Minister for Health if she will introduce a national scheme for improved access to emergency anaphylaxis medication, including adrenaline auto-injectors, along with structured training and guidance for schools, childcare providers and public settings; and if she will make a statement on the matter. [69648/25]
1000. Deputy Albert Dolan asked the Minister for Health if she will work with the Minister for Education and Youth to ensure that all schools have access to stock adrenaline auto-injectors, rather than relying on individual students and their families to supply them; the measures being taken to provide mandatory, standardised training for teachers and school staff so they feel confident and safe in administering auto…